Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 7
2006 8
2007 7
2008 15
2009 16
2010 35
2011 45
2012 44
2013 45
2014 48
2015 38
2016 59
2017 24
2018 19
2019 18
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

411 results
Results by year
Filters applied: . Clear all
Page 1
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8. Lancet. 2018. PMID: 30496104 Free PMC article.
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Risk Factor Collaborators. GBD 2017 Risk Factor Collaborators. Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8. Lancet. 2018. PMID: 30496105 Free PMC article.
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 DALYs and HALE Collaborators. GBD 2017 DALYs and HALE Collaborators. Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3. Lancet. 2018. PMID: 30415748 Free PMC article.
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
Daneshi-Maskooni M, Keshavarz SA, Qorbani M, Mansouri S, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G. Daneshi-Maskooni M, et al. Among authors: alavian sm. BMC Complement Altern Med. 2019 Mar 12;19(1):59. doi: 10.1186/s12906-019-2465-0. BMC Complement Altern Med. 2019. PMID: 30871514 Free PMC article. Clinical Trial.
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Daneshi-Maskooni M, Keshavarz SA, Mansouri S, Qorbani M, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G. Daneshi-Maskooni M, et al. Among authors: alavian sm. Trials. 2017 Jun 7;18(1):260. doi: 10.1186/s13063-017-1979-3. Trials. 2017. PMID: 28592311 Free PMC article. Clinical Trial.
Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
Cheraghpour M, Imani H, Ommi S, Alavian SM, Karimi-Shahrbabak E, Hedayati M, Yari Z, Hekmatdoost A. Cheraghpour M, et al. Among authors: alavian sm. Phytother Res. 2019 Aug;33(8):2118-2125. doi: 10.1002/ptr.6406. Epub 2019 Jul 1. Phytother Res. 2019. PMID: 31264313 Clinical Trial.
Art and viral hepatitis elimination programmes.
Nima M, Karimi-Sari H, Alavian SM. Nima M, et al. Among authors: alavian sm. J Virus Erad. 2018 Jan 1;4(1):59-60. J Virus Erad. 2018. PMID: 29568557 Free PMC article.
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level.
Karimzadeh H, Kiraithe MM, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze Zur Wiesch J, Budeus B, Hoffmann D, Wedemeyer H, Cornberg M, Krawczyk A, Rashidi-Alavijeh J, Rodríguez-Frías F, Casillas R, Buti M, Smedile A, Alavian SM, Heinold A, Emmerich F, Panning M, Gostick E, Price DA, Timm J, Hofmann M, Raziorrouh B, Thimme R, Protzer U, Roggendorf M, Neumann-Haefelin C. Karimzadeh H, et al. Among authors: alavian sm. Gastroenterology. 2019 May;156(6):1820-1833. doi: 10.1053/j.gastro.2019.02.003. Epub 2019 Feb 12. Gastroenterology. 2019. PMID: 30768983 Free PMC article.
Fas and FasL promoter polymorphisms and susceptibility to HBV infection: A systematic review and meta-analysis.
Mohammadi A, Salehi M, Khanbabaei H, Sheikhesmaeili F, Tajik N, Alavian SM. Mohammadi A, et al. Among authors: alavian sm. Infect Genet Evol. 2019 Dec;76:104003. doi: 10.1016/j.meegid.2019.104003. Epub 2019 Aug 16. Infect Genet Evol. 2019. PMID: 31425784
Effects of a Low-Calorie, Low-Carbohydrate Soy Containing Diet on Systemic Inflammation Among Patients with Nonalcoholic Fatty Liver Disease: A Parallel Randomized Clinical Trial.
Kani AH, Alavian SM, Esmaillzadeh A, Adibi P, Haghighatdoost F, Azadbakht L. Kani AH, et al. Among authors: alavian sm. Horm Metab Res. 2017 Sep;49(9):687-692. doi: 10.1055/s-0042-118707. Epub 2017 Jul 31. Horm Metab Res. 2017. PMID: 28759939 Clinical Trial.
411 results
Jump to page
Feedback